Our top pick for
Forterra Inc is a building products & equipment business based in the US. Forterra shares (FRTA) are listed on the NASDAQ and all prices are listed in US Dollars. Forterra employs 4,824 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$24.00|
|52-week range||$22.60 - $24.01|
|50-day moving average||$23.55|
|200-day moving average||$23.63|
|Wall St. target price||$24.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.67|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-20)||N/A|
|1 month (2022-05-28)||N/A|
|3 months (2022-03-28)||N/A|
|6 months (2021-12-31)||0.93%|
|1 year (2021-07-01)||2.30%|
|2 years (2020-07-01)||102.36%|
|3 years (2019-07-01)||361.54%|
|5 years (2017-06-30)||191.62%|
Valuing Forterra stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Forterra's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Forterra's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Forterra shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Forterra's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.54. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Forterra's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Forterra's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $299.6 million.
The EBITDA is a measure of a Forterra's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.9 billion|
|Operating margin TTM||11.68%|
|Gross profit TTM||$420.4 million|
|Return on assets TTM||7.9%|
|Return on equity TTM||45.36%|
|Market capitalisation||$1.6 billion|
TTM: trailing 12 months
We're not expecting Forterra to pay a dividend over the next 12 months.
Over the last 12 months, Forterra's shares have ranged in value from as little as $22.6 up to $24.01. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Forterra's is 2.1924. This would suggest that Forterra's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Forterra, Inc. , through its subsidiaries, manufactures and sells pipe and precast products in the United States, Canada, and Mexico. It operates through Drainage Pipe & Products; and Water Pipe & Products segments. The company offers concrete drainage pipes used for storm water applications, residential and non-residential site developments, sanitary sewers, low-pressure sewer force mains, tunneled systems, treatment plant piping, and utility tunnels; precast concrete products, including box culverts, utility vaults, manholes, drainage inlets, and pipe end sections used for roadway and airport drainage, storm water management, utility construction, and water treatment and filtration systems; and architectural panels for buildings, modular railroad crossings, retaining wall and storm water treatment systems, highway noise barriers, and concrete vaults that are used to house dry or wet utilities. It also provides hollow-core planks, prestressed bridge girders, beams, columns, wall panels, stairs, garage floors, and architectural claddings for parking garages and arched and modular bridges; precast concrete bridge girders for highway projects; precast concrete foundation to support prefabricated shelters or equipment buildings; precast product that consolidates and protects underground electrical and communication cables; and storm water technologies for storm water management market. In addition, the company offers ductile iron pipes for transmission and distribution of potable and wastewater; concrete pressure pipes for water transmission and distribution, power plant cooling water lines, sewage force mains for waste and storm water, and other applications; and prestressed concrete and bar-wrapped concrete pipes. The company was founded in 1899 and is headquartered in Irving, Texas.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.